Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients

BACKGROUND: Biomarkers to objectively measure disease severity and predict therapeutic responses are needed in atopic dermatitis (AD). OBJECTIVE: Primary aim: To identify biomarkers reflecting therapeutic response in patients with AD treated systemically. Secondary aims: (i) To identify a biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Roekevisch, E., Szegedi, K., Hack, D.P., Schram, M.E., Res, P.C.J.M., Bos, J.D., Leeflang, M.M.G., Luiten, R.M., Kezic, S., Spuls, P.I., Middelkamp‐Hup, M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Allergy and Eczema
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496710/
https://www.ncbi.nlm.nih.gov/pubmed/31855303
http://dx.doi.org/10.1111/jdv.16164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496710/
https://www.ncbi.nlm.nih.gov/pubmed/31855303
http://dx.doi.org/10.1111/jdv.16164

Ejemplares similares